Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drasar, BS & MJ Hill (1974). Composition of the gut flora. Human intestinal flora. Vol. (BS Drasar and MJ Hill, eds.), pp. 26-35 Academic Press Inc. Ltd., London.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces and clinical sources (blood, sputum, wound - CCUG)
DNA G+C(%): 54.9-56.8
|
Opt. T: 37℃
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: Var(MIC50): 1, MIC90: 2
ampicillin: Var(MIC50): 0.5, MIC90: 32, RNG: (0.03–>32)
penicillin: SensRNG: (<0.03-0.12)
piper-taz: Var(MIC50): 4, MIC90: 32, RNG: (0.03–>128)
ertapenem: S(0.5)
imipenem: Var(MIC50): 0.04, MIC90: 32, RNG: (0.03–>32)
meropenem: S(0.25)
|
cefepime: S(0.05)
cefotaxime: S(0.12)
cefuroxime: S(0.5)
|
gentamicin: S(2)
|
azithromycin: Var(MIC50): ≤0.015->128), MIC90: Var(≤0.015->128
erythromycin: R(0.25->4,vr)
clarithromycin: SensRNG: (≤0.015-4)
quin-dalf: S(MIC50): 0.5, MIC90: 0.5, RNG: (0.125-2)
roxithromycin: Var(MIC50): ≤0.015-16), MIC90: Var(≤0.015-16
|
linezolid: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.125-0.5)
ciprofloxacin: S(0.5)
levofloxacin: SensRNG: (0.25-1)
moxifloxacin: S(1)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: SensRNG: (0.12-0.25)
tetracycline: SensRNG: (1-2)
tigecycline: S(0.12)
|
vancomycin: SensRNG: (0.05-1)
|
rifampicin: S(0.5)
|
chloramphenicol: SensRNG: (2-4)
SXT: S(MIC50): 0.5, MIC90: 9.5, RNG: (<0.5->76)
|
clindamycin: R(0.12->2,vr)
daptomycin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.125-0.5)
|